Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.
01 1VAMSI LABS LIMITED.
02 1Aarti Pharmalabs Limited
03 1Neuland Laboratories Limited
04 1Amphastar Nanjing Pharmaceuticals, Inc.
05 1Boehringer Ingelheim Pharma GmbH and Co. KG
06 1Cipla Ltd.
07 1Derivados Quimicos
08 1Lusochimica SPA
09 1Lusochimica SpA
10 1Olon SpA
11 3Professional Compounding Centers of America dba PCCA
12 1Saurav Chemicals Limited
13 1Spectrum Laboratory Products, Inc.
01 3IPARTROPIUM BROMIDE
02 1IPRATROPIUM BROMIDE
03 8Ipratropium Bromide
04 1Ipratropium Bromide Monohydrate
05 1Ipratropium bromide
06 1ipratropium bromide
01 1Germany
02 5India
03 3Italy
04 1Spain
05 2U.S.A
06 3United Kingdom
Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.
NDC Package Code : 66412-0753
Start Marketing Date : 2019-09-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
NDC Package Code : 15308-1001
Start Marketing Date : 2002-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 58032-0100
Start Marketing Date : 2015-04-11
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/1)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 12714-049
Start Marketing Date : 2011-05-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 43898-0135
Start Marketing Date : 1994-01-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 43898-0102
Start Marketing Date : 1991-02-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0520
Start Marketing Date : 2017-02-22
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-0079
Start Marketing Date : 2020-07-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 43235-0013
Start Marketing Date : 2020-05-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49452-3791
Start Marketing Date : 2000-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Ipratropium Bromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ipratropium Bromide, including repackagers and relabelers. The FDA regulates Ipratropium Bromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ipratropium Bromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ipratropium Bromide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ipratropium Bromide supplier is an individual or a company that provides Ipratropium Bromide active pharmaceutical ingredient (API) or Ipratropium Bromide finished formulations upon request. The Ipratropium Bromide suppliers may include Ipratropium Bromide API manufacturers, exporters, distributors and traders.
click here to find a list of Ipratropium Bromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ipratropium Bromide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ipratropium Bromide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ipratropium Bromide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ipratropium Bromide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ipratropium Bromide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ipratropium Bromide suppliers with NDC on PharmaCompass.
We have 12 companies offering Ipratropium Bromide
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?